Join
Live feed
·
INSIDERFilingvia Quantisnow
VYNE Therapeutics Inc. logo

New insider Ai Biotechnology Llc claimed ownership of 1,116,585 shares (SEC Form 3)

ByQuantisnow·Wall Street's wire, on your screen.
VYNE· VYNE Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track VYNE (VYNE Therapeutics Inc.) and more on Quantisnow.